# Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

> **NCT00134511** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 30 (—)

## Conditions studied

- Hypercholesterolemia, Familial

## Interventions

- **DRUG:** Torcetrapib/atorvastatin

## Key facts

- **NCT ID:** NCT00134511
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 30 (—)
- **Last updated:** 2007-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00134511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00134511, "Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00134511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*